Tandem Diabetes Care, Inc. (TNDM)
| Previous close | 34.97 |
| Open | 34.95 |
| Bid | 34.95 x 200 |
| Ask | 35.25 x 200 |
| Day's range | 34.36 - 35.52 |
| 52-week range | 13.82 - 40.74 |
| Volume | |
| Avg. volume | 1,737,879 |
| Market cap | 2.267B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.43 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 36.14 |
Business WireTandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
SAN DIEGO, April 09, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
Simply Wall St.Bullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of Stock
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
Insider MonkeyShould You Invest in Tandem Diabetes Care (TNDM)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds released “The RiverPark/Next Century Growth Fund” Q4 2023 investor letter in partnership with Next Century Growth Investors, LLC. A copy of the same can be downloaded here. The fund returned 4.75% in the fourth quarter compared to a 12.75% return […]
